Category Archives: Clinical Collaborations

OneOme Making Progress in Pharmacogenomics

Pharmacogenomics is one of the key aspects of personalized medicine, focusing on how an individual’s DNA affects the way they respond to medications. All individuals have different genetic make-up so they respond differently to the same medication. Based on this insight, pharmacogenomics allows customized treatment for a wide range of health problems including; cardiovascular disease, […]

AetnaCare Boosted by Merck Collaboration

AetnaCare Boosted by Merck Collaboration: Aetna has announced AetnaCare℠, a new program designed to offer members an integrated care plan so they have the knowledge, motivation and confidence to manage their own health. Over 40% of Aetna’s medical spend currently runs through some form of value-based care model today and the company is developing programs like […]

Increasing Demand for Drug Based Outcomes

Specialty Pharma Services

Increasing Demand for Drug Based Outcomes – Outcome-based contracts are a relatively new and growing contracting methodology focused on shifting reimbursement from volume to value. The contracts are between a health plan and manufacturer where reimbursement is dependent on pre-defined outcome metrics focused on improving patient responses/health. Currently, the relationship between the pharmaceutical manufacturer, the […]

Clinical trial collaborations – an idea whose time has come

The cost and time commitment to develop new drugs has increased significantly over the last few decades. A variety of factors come into play, but on average, in terms of total expenditures, it has taken from $3 to $5 billion and up to 15 years to bring a new drug to market. Even after all […]